ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2025
Streamlined Testosterone Order Template to Improve the Diagnosis and Evaluation of Hypogonadism in Veterans.
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Poor adherence to evidence-based guidelines for diagnosing hypogonadism prior to initiating testosterone replacement therapy (TRT), has prompted recommendations for clinical practice improvement. This quality improvement study examined whether a testosterone order template (TOT) could improve adherence to evidence-based guidelines. Methods: A retrospective review examined male patients aged > 18 years with no prior VA testosterone prescription and ≥ 2 clinic visits who received a new testosterone prescription before TOT implementation vs postimplementation. Signs and symptoms of hypogonadism, ≥ 2 serum testosterone and gonadotropin measurements, TRT risks and benefits, and an updated hematocrit test within 6 months prior to TRT were documented. Results: Fifty-six patients in the pretemplate period and 40 patients in the posttemplate period were included. In the posttemplate period, 37 patients (93%) had documented signs and symptoms of hypogonadism compared with 40 patients (71%) in the pretemplate period ( Conclusions: TOT implementation is a feasible approach to improve clinical diagnosis and hypogonadism evaluation before TRT. The low proportion of men who received education regarding the risks and benefits of TRT and adherence to guideline recommendations after implementation underscores the need for additional efforts to improve guideline adherence and clinical practice.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.